117 related articles for article (PubMed ID: 9675959)
1. [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients].
Cice G; Tagliamonte E; Ferrara L; Di Benedetto A; Iacono A
Cardiologia; 1998 Jun; 43(6):597-604. PubMed ID: 9675959
[TBL] [Abstract][Full Text] [Related]
2. Effects of carvedilol on ventricular arrhythmias.
Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
Cice G; Tagliamonte E; Ferrara L; Iacono A
Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
Miki S; Masumura H; Kaifu Y; Yuasa S
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S62-8. PubMed ID: 1721982
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients.
Masumura H; Miki S; Kaifu Y; Kitajima W; Abe Y
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S102-7. PubMed ID: 1378134
[TBL] [Abstract][Full Text] [Related]
7. Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.
Inrig JK; Van Buren P; Kim C; Vongpatanasin W; Povsic TJ; Toto R
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1300-9. PubMed ID: 22700888
[TBL] [Abstract][Full Text] [Related]
8. The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.
Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM;
Am J Kidney Dis; 2016 Jun; 67(6):902-11. PubMed ID: 26717861
[TBL] [Abstract][Full Text] [Related]
9. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
Xiaozhen H; Yun Z; Mei Z; Yu S
Blood Press; 2010 Feb; 19(1):40-7. PubMed ID: 20001392
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
11. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol--clinical experience in arrhythmias.
Storstein L
Cardiology; 1993; 82 Suppl 3():29-33. PubMed ID: 8106161
[TBL] [Abstract][Full Text] [Related]
13. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
Wright DJ; Cooke GA; Tan LB
Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
[No Abstract] [Full Text] [Related]
14. Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.
Kanoupakis EM; Manios EG; Mavrakis HE; Kallergis EM; Lyrarakis GM; Koutalas EP; Vardas PE
Cardiovasc Drugs Ther; 2008 Jun; 22(3):169-76. PubMed ID: 18205033
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
16. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
Langdon CG; Baxter GA; Young PH
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
[TBL] [Abstract][Full Text] [Related]
17. Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy.
Bøttcher M; Refsgaard J; Gøtzsche O; Andreasen F; Nielsen TT
Am J Cardiol; 2002 Jun; 89(12):1388-93. PubMed ID: 12062733
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
Neglia D; De Maria R; Masi S; Gallopin M; Pisani P; Pardini S; Gavazzi A; L'abbate A; Parodi O
Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effectivenes of treatment of patients with renal arterial hypertension with carvedilol].
Rakov AL; Nikitin AV; Riabov AIu
Klin Med (Mosk); 2006; 84(6):35-8. PubMed ID: 16875066
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of carvedilol in severe hypertension.
Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
